Biodexa Pharmaceuticals BDRX
NASDAQ BDRX
$0.66 +0.01 (+1.71%)
At close: Sep 30, 2026 · 4:00 PM EDT

Biodexa Pharmaceuticals (BDRX) Finished Goods (2015 - 2017)

Updated

Biodexa Pharmaceuticals (BDRX) reported Finished Goods of $1.25 million for the quarter ended Dec 31, 2017, up 23.0% from $1.02 million a year earlier.

Analysis

Biodexa Pharmaceuticals (BDRX) Finished Goods (2015 - 2017) Analysis & Trends

As of Dec 31, 2017, Biodexa Pharmaceuticals posted Finished Goods of $1.21 million, up 9.4% from the prior year.

  • By year, Finished Goods came in at $1.11 million in the year ended Dec 31, 2016 (+216.5%) and $350,169 in the year ended Dec 31, 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Biodexa Pharmaceuticals 41.06 Mn 17.85 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 1.25 Mn
Dec 31, 2016 1.02 Mn
Dec 31, 2015 347,505.33
API Access

Biodexa Pharmaceuticals Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=BDRX&period=max&api_key=YOUR_API_KEY